Qlife Holding AB (publ) (QLIFE.ST)
SEK 1.92
(-2.54%)
SEK 1.92
(-2.54%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.29 Million SEK | -9.64% |
| 2022 | 8.07 Million SEK | -2.88% |
| 2021 | 8.3 Million SEK | 54.53% |
| 2020 | 5.37 Million SEK | 136.2% |
| 2019 | 2.27 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 7.84 Million SEK | 7.61% |
| 2024 Q2 | 8.08 Million SEK | 3.07% |
| 2023 Q4 | 7.29 Million SEK | -7.37% |
| 2023 Q2 | 7.84 Million SEK | 1.9% |
| 2023 FY | 7.29 Million SEK | -9.64% |
| 2023 Q1 | 7.69 Million SEK | -4.65% |
| 2023 Q3 | 7.87 Million SEK | 0.4% |
| 2022 Q1 | 11.62 Million SEK | 39.93% |
| 2022 FY | 8.07 Million SEK | -2.88% |
| 2022 Q2 | 12.66 Million SEK | 8.91% |
| 2022 Q3 | 18.59 Million SEK | 46.87% |
| 2022 Q4 | 8.07 Million SEK | -56.61% |
| 2021 FY | 8.3 Million SEK | 54.53% |
| 2021 Q1 | 6.24 Million SEK | 16.12% |
| 2021 Q3 | 9.48 Million SEK | 39.78% |
| 2021 Q4 | 8.3 Million SEK | -12.42% |
| 2021 Q2 | 6.78 Million SEK | 8.7% |
| 2020 Q1 | 3.5 Million SEK | 53.92% |
| 2020 Q2 | 5.32 Million SEK | 51.86% |
| 2020 FY | 5.37 Million SEK | 136.2% |
| 2020 Q4 | 5.37 Million SEK | -7.74% |
| 2020 Q3 | 5.82 Million SEK | 9.53% |
| 2019 FY | 2.27 Million SEK | 0.0% |
| 2019 Q4 | 2.27 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -6.624% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 93.983% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 93.983% |
| Arcoma AB | 28.02 Million SEK | 73.982% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 75.403% |
| BICO Group AB (publ) | 493.1 Million SEK | 98.521% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 88.314% |
| CellaVision AB (publ) | 126.03 Million SEK | 94.214% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -19.248% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -311.763% |
| C-Rad AB (publ) | 64.09 Million SEK | 88.624% |
| Duearity AB (publ) | 4.15 Million SEK | -75.331% |
| Dignitana AB (publ) | 7.41 Million SEK | 1.632% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -97.081% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.886% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 533.178% |
| Iconovo AB (publ) | -4.86 Million SEK | 249.979% |
| Integrum AB (publ) | 22.36 Million SEK | 67.391% |
| Luxbright AB (publ) | 8000.00 SEK | -91050.0% |
| Mentice AB (publ) | 14.1 Million SEK | 48.298% |
| OssDsign AB (publ) | 4.3 Million SEK | -69.424% |
| Paxman AB (publ) | 19.99 Million SEK | 63.538% |
| Promimic AB (publ) | 330 Thousand SEK | -2109.697% |
| SciBase Holding AB (publ) | 11.91 Million SEK | 38.82% |
| ScandiDos AB (publ) | 22.69 Million SEK | 67.862% |
| Sectra AB (publ) | 36.59 Million SEK | 80.071% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 83.032% |
| Senzime AB (publ) | 20.34 Million SEK | 64.149% |
| SpectraCure AB (publ) | 1.00 SEK | -729199900.0% |
| Stille AB | 66.55 Million SEK | 89.043% |
| Vitrolife AB (publ) | 413 Million SEK | 98.234% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 94.85% |